6:41 PM
 | 
Mar 02, 2009
 |  BC Extra  |  Company News

ImClone, Bristol-Myers get Erbitux complete response

Eli Lilly (NYSE:LLY) subsidiary ImClone and Bristol-Myers (NYSE:BMY) said they received a complete response letter from FDA for an sBLA to...

Read the full 98 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Extra

Article Purchase

$50 USD
More Info >